CSL Vifor Competitors and Similar CompaniesClear all

CSL Vifor's competitors and similar companies include Nature's Toolbox (NTx), Liverpool ChiroChem, AbbVie and Patheon.

	CSL Vifor CSL Vifor (also known as Vifor Pharma Management) is a diversified group active throughout the healthcare market, which develops, manufactures, and markets pharmaceutical products.	Nature's Toolbox (NTx) Nature's Toolbox (NTx) is a bioinformatics and biomanufacturing company.	Liverpool ChiroChem Liverpool ChiroChem is a company that produces chiral small molecules intended to help in biotech, pharmaceutical, and research and development.	AbbVie AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies.	Patheon Patheon is a company that provides commercial manufacturing and pharmaceutical development services.
Founding Date	Founding Date 1927	Founding Date 2015	Founding Date 2014	Founding Date 2013	Founding Date 2014
Type	Type Subsidiary	Type Private	Type Private	Type Public	Type Subsidiary
Tags	Tags Manufacturing & Industrial drug development healthtech pharma	Tags Healthcare Manufacturing & Industrial biotech drug development healthtech pharma	Tags Manufacturing & Industrial biotech chemicals drug development healthtech pharma	Tags Healthcare biotech drug development pharma	Tags Manufacturing & Industrial drug development pharma
Locations	Locations Glattbrugg, CH HQ Buenos Aires, AR Melbourne, AU Melbourne, AU Wien, AT Antwerpen, BE São Paulo, BR see more	Locations Rio Rancho, US HQ	Locations Liverpool, GB HQ Liverpool, GB	Locations North Chicago, US HQ Hydra, DZ Buenos Aires, AR Mascot, AU Wien, AT Wavre, BE Sarajevo, BA see more	Locations Mississauga, CA HQ
Employees	Employees 2,200	Employees 532% decrease	Employees 2411% decrease	Employees 55,00010% increase	Employees 6,500
Financial
Revenue (est.)	Revenue (est.) CHF1.8b (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $61.2b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods CHF498.7m (FY, 2021)	Cost of goods N/A	Cost of goods N/A	Cost of goods $18.2b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit CHF1.3b (FY, 2021)	Gross profit N/A	Gross profit N/A	Gross profit $43b (FY, 2025)	Gross profit N/A
Net income	Net income CHF265.4m (FY, 2021)	Net income N/A	Net income N/A	Net income $4.2b (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 13m (over 6 years ago)	Latest funding round $ 2.8m (about 6 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 13.3m	Total funding raised $ 4.1m	Total funding raised $ 3.8b	Total funding raised $ 150m